An in situ -forming injectable silk hydrogel with a cocktail of chemotherapeutic drugs simultaneously targeting cancer cells and cancer stem cells
Abstract
silk injectable hydrogel with sustained dual-drug release effectively eliminates both bulk tumor cells and bCSCs, making this injectable silk hydrogel a promising strategy for reducing breast cancer stem cells, which may reduce the chances of recurrence and enhance therapeutic outcomes.
Fields of Study & Subjects
Silk-based biomaterials and applications
Hydrogels: synthesis
properties
applications
Nanoplatforms for cancer theranostics
Publication details
- Journal / source
- Journal of Materials Chemistry B
- Publisher
- Royal Society of Chemistry (RSC)
- Volume
- 14
- Issue
- 8
- Pages
- 2612–2629
- Publication date
- 1 January 2026
- Language
- EN